Veracyte Inc (VCYT) with a beta value of 1.64 appears to be a promising investment opportunity.

On Tuesday, Veracyte Inc (NASDAQ: VCYT) was 3.58% jump from the session before ,before settling in for the closing price of $20.69. A 52-week range for VCYT has been $19.52 – $30.52.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 34.42% over the last five years. When this article was written, the company’s average yearly earnings per share was at 74.74%. With a float of $73.82 million, this company’s outstanding shares have now reached $75.07 million.

The firm has a total of 815 workers. Let’s measure their productivity.

Veracyte Inc (VCYT) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Veracyte Inc stocks. The insider ownership of Veracyte Inc is 1.66%, while institutional ownership is 99.68%. The most recent insider transaction that took place on Apr 01 ’24, was worth 216,528. In this transaction Director of this company sold 10,000 shares at a rate of $21.65, taking the stock ownership to the 33,125 shares. Before that another transaction happened on Mar 01 ’24, when Company’s Director sold 10,000 for $24.36, making the entire transaction worth $243,599. This insider now owns 37,601 shares in total.

Veracyte Inc (VCYT) Recent Fiscal highlights

Going through the last 3-months fiscal report unveiled on the 12/30/2023, it has been observed that the corporation posted -$0.39 earnings per share (EPS) during the time that was less than consensus figure (set at -$0.09) by -$0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 74.74% per share during the next fiscal year.

Veracyte Inc (NASDAQ: VCYT) Trading Performance Indicators

You can see what Veracyte Inc (VCYT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.46. Likewise, its price to free cash flow for the trailing twelve months is 46.96.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.02, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.04 in one year’s time.

Technical Analysis of Veracyte Inc (VCYT)

Analysing the last 5-days average volume posted by the [Veracyte Inc, VCYT], we can find that recorded value of 0.55 million was lower than the volume posted last year of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 39.04%. Additionally, its Average True Range was 0.87.

During the past 100 days, Veracyte Inc’s (VCYT) raw stochastic average was set at 17.76%, which indicates a significant decrease from 65.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.16% in the past 14 days, which was lower than the 51.09% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $23.12, while its 200-day Moving Average is $24.64. Now, the first resistance to watch is $21.69. This is followed by the second major resistance level at $21.95. The third major resistance level sits at $22.45. If the price goes on to break the first support level at $20.93, it is likely to go to the next support level at $20.43. Now, if the price goes above the second support level, the third support stands at $20.17.

Veracyte Inc (NASDAQ: VCYT) Key Stats

There are 75,068K outstanding shares of the company, which has a market capitalization of 1.61 billion. As of now, sales total 361,050 K while income totals -74,400 K. Its latest quarter income was 98,200 K while its last quarter net income were -28,290 K.